Vetirus Pharmaceuticals, a global leader in biologic therapies for human and veterinary health, announces its acquisition of Enso Discoveries, LLC, a Manhattan, Kansas-based biotech company specializing in regenerative medicine. This strategic acquisition enhances Vetirus’ capabilities in delivering innovative and cost-effective solutions to improve the lives of animals and humans worldwide. Enso Discoveries is renowned for its development of cutting-edge products such as Rebound PRP™ and Rebound PRF®, which are widely used in veterinary and human health markets. These patented regenerative medicine kits provide accessible and validated therapies that promote optimal healing.
Read the full article: Vetirus Pharmaceuticals Acquires Enso Discoveries to Expand Regenerative Medicine Portfolio //
Source: https://www.pr.com/press-release/937391